Published in J Proteome Res on March 15, 2012
Schwann cell autophagy, myelinophagy, initiates myelin clearance from injured nerves. J Cell Biol (2015) 1.07
S-adenosylmethionine levels regulate the schwann cell DNA methylome. Neuron (2014) 0.95
Excess S-adenosylmethionine reroutes phosphatidylethanolamine towards phosphatidylcholine and triglyceride synthesis. Hepatology (2013) 0.94
Serum metabolomic profile and potential biomarkers for severity of fibrosis in nonalcoholic fatty liver disease. J Gastroenterol (2013) 0.85
Metabolomic profiles of hepatocellular carcinoma in a European prospective cohort. BMC Med (2015) 0.85
Biomarkers in nonalcoholic fatty liver disease. Can J Gastroenterol Hepatol (2014) 0.84
Nonalcoholic fatty liver disease: update on pathogenesis, diagnosis, treatment and the role of S-adenosylmethionine. Exp Biol Med (Maywood) (2015) 0.81
Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology. World J Gastroenterol (2015) 0.78
Urine and serum metabolomic profiling reveals that bile acids and carnitine may be potential biomarkers of primary biliary cirrhosis. Int J Mol Med (2015) 0.77
Methionine and S-adenosylmethionine levels are critical regulators of PP2A activity modulating lipophagy during steatosis. J Hepatol (2015) 0.76
Systems biology for hepatologists. Hepatology (2014) 0.76
Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis. Gastroenterology (2017) 0.75
High-melting lipid mixtures and the origin of detergent-resistant membranes studied with temperature-solubilization diagrams. Biophys J (2014) 0.75
Synthesis and anti-obesity effects in vivo of Crotadihydrofuran C as a novel PPARγ antagonist from Crotalaria albida. Sci Rep (2017) 0.75
Data in support of enhancing metabolomics research through data mining. Data Brief (2015) 0.75
Metabolomic signatures associated with disease severity in multiple sclerosis. Neurol Neuroimmunol Neuroinflamm (2017) 0.75
Serum metabolomic profiling highlights pathways associated with liver fat content in a general population sample. Eur J Clin Nutr (2017) 0.75
Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology (2005) 29.57
Nonalcoholic fatty liver disease. N Engl J Med (2002) 22.41
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology (1999) 11.76
Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest (2005) 9.09
Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology (2001) 8.09
Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology (2010) 8.05
Human fatty liver disease: old questions and new insights. Science (2011) 8.03
Liver biopsy. Hepatology (2009) 7.61
Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology (2005) 7.03
Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology (2010) 5.44
Systems biology: Metabonomics. Nature (2008) 5.32
Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity. Nature (2011) 4.78
The plasma lipidomic signature of nonalcoholic steatohepatitis. Hepatology (2009) 3.48
Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology (2003) 3.42
Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites. Hepatology (2010) 3.11
Analysis of nonvolatile lipids by mass spectrometry. Chem Rev (2001) 2.79
Adipose tissue as a buffer for daily lipid flux. Diabetologia (2002) 2.65
The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis. Eur Radiol (2010) 2.05
Methionine metabolism and liver disease. Annu Rev Nutr (2008) 1.98
Rats selectively bred for low aerobic capacity have reduced hepatic mitochondrial oxidative capacity and susceptibility to hepatic steatosis and injury. J Physiol (2009) 1.95
Association of lipidome remodeling in the adipocyte membrane with acquired obesity in humans. PLoS Biol (2011) 1.89
Plasma metabolomic profile in nonalcoholic fatty liver disease. Metabolism (2010) 1.77
Pathology of nonalcoholic fatty liver disease. Am J Clin Pathol (2007) 1.76
Steatohepatitis, spontaneous peroxisome proliferation and liver tumors in mice lacking peroxisomal fatty acyl-CoA oxidase. Implications for peroxisome proliferator-activated receptor alpha natural ligand metabolism. J Biol Chem (1998) 1.60
Role of mitochondria in non-alcoholic fatty liver disease. J Gastroenterol Hepatol (2007) 1.52
Obesity and nonalcoholic fatty liver disease. Nutr Rev (2007) 1.51
Analytical error reduction using single point calibration for accurate and precise metabolomic phenotyping. J Proteome Res (2009) 1.48
Lipidomic dissection of nonalcoholic steatohepatitis: moving beyond foie gras to fat traffic. Hepatology (2010) 1.43
Metabolic profiling of plasma in overweight/obese and lean men using ultra performance liquid chromatography and Q-TOF mass spectrometry (UPLC-Q-TOF MS). J Proteome Res (2010) 1.42
Temporal pattern of de novo lipogenesis in the postprandial state in healthy men. Am J Clin Nutr (2005) 1.40
Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease. J Proteome Res (2010) 1.29
Disappearance of plasmalogens from membranes of animal cells subjected to photosensitized oxidation. J Biol Chem (1988) 1.21
Hepatic secretion of VLDL fatty acids during stimulated lipogenesis in men. J Lipid Res (1998) 1.18
Sphingolipid signalling and liver diseases. Liver Int (2007) 1.13
NASH--hepatic metabolism and not simply the metabolic syndrome. Hepatology (2003) 1.01
The measurement of carnitine and acyl-carnitines: application to the investigation of patients with suspected inherited disorders of mitochondrial fatty acid oxidation. Clin Chim Acta (1992) 0.89
No need for a large belly to have NASH. J Hepatol (2011) 0.87
Fatty acids, insulin resistance, and protein metabolism. J Clin Endocrinol Metab (2009) 0.86
Where are we in the search for noninvasive nonalcoholic steatohepatitis biomarkers? Hepatology (2011) 0.82
Genetic susceptibility to hepatic steatosis. N Engl J Med (2010) 0.81
Three for the price of one knockout--a mouse model of a congenital peroxisomal disorder, steatohepatitis, and hepatocarcinogenesis. Hepatology (1999) 0.77
Community-based approaches to HIV treatment in resource-poor settings. Lancet (2001) 7.13
The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level. Oncogene (2008) 5.85
A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat Genet (1998) 4.13
Hypoinsulinaemia, glucose intolerance and diminished beta-cell size in S6K1-deficient mice. Nature (2001) 3.65
The stomach is a source of leptin. Nature (1998) 3.33
Do not use epinephrine in digital blocks: myth or truth? Plast Reconstr Surg (2001) 3.17
Mps1 is a kinetochore-associated kinase essential for the vertebrate mitotic checkpoint. Cell (2001) 3.16
Fizzy is required for activation of the APC/cyclosome in Xenopus egg extracts. EMBO J (1998) 3.02
Compensated cirrhosis: natural history and prognostic factors. Hepatology (1987) 3.01
Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J Clin Invest (2000) 3.00
Methionine adenosyltransferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation. Proc Natl Acad Sci U S A (2001) 2.93
A Pluto-like radius and a high albedo for the dwarf planet Eris from an occultation. Nature (2011) 2.91
Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients. Hepatology (2001) 2.69
Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles. Hum Reprod (2010) 2.65
Is cisplatin-induced cell death always produced by apoptosis? Mol Pharmacol (2001) 2.56
Case definition and phenotype standardization in drug-induced liver injury. Clin Pharmacol Ther (2011) 2.50
Signal input for a chemotactic response in the cellular slime mold Dictyostelium discoideum. Proc Natl Acad Sci U S A (1975) 2.44
A genome-wide scan for human obesity genes reveals a major susceptibility locus on chromosome 10. Nat Genet (1998) 2.44
Comparison of two clinical scales for causality assessment in hepatotoxicity. Hepatology (2001) 2.40
Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma. J Hepatol (2000) 2.22
C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet. Diabetologia (2007) 2.19
Distinct phenotype of hepatotoxicity associated with illicit use of anabolic androgenic steroids. Aliment Pharmacol Ther (2014) 2.17
S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial. J Hepatol (1999) 2.14
Plasma carnitine is associated with fatigue in chronic hepatitis C but not in the irritable bowel syndrome. Aliment Pharmacol Ther (2011) 2.08
Current concepts in the pathogenesis of alcoholic liver injury. FASEB J (2001) 2.08
Biomedical ontologies: toward scientific debate. Methods Inf Med (2011) 2.07
[Cyclosporin A and plasma lipoproteins]. Med Clin (Barc) (1994) 2.04
Latent autoimmune hepatitis triggered during interferon therapy in patients with chronic hepatitis C. Gastroenterology (1995) 2.02
Apparent diffusion coefficient histogram analysis stratifies progression-free survival in newly diagnosed bevacizumab-treated glioblastoma. AJNR Am J Neuroradiol (2011) 2.00
Regulation by hypoxia of methionine adenosyltransferase activity and gene expression in rat hepatocytes. Gastroenterology (1998) 1.96
Primary pancreatic beta-cell secretory defect caused by mutations in glucokinase gene in kindreds of maturity onset diabetes of the young. Lancet (1992) 1.95
The lipid phosphatase SHIP2 controls insulin sensitivity. Nature (2001) 1.90
Nonnucleoside human cytomegalovirus inhibitors: synthesis and antiviral evaluation of (chlorophenylmethyl)benzothiadiazine dioxide derivatives. J Med Chem (2000) 1.86
Insulin binding and effects in isolated soleus muscle of lean and obese mice. Am J Physiol (1978) 1.84
Serine/threonine phosphorylation of insulin receptor substrate 1 modulates insulin receptor signaling. J Biol Chem (1994) 1.84
Histological course of alcoholic hepatitis. Influence of abstinence, sex and extent of hepatic damage. J Hepatol (1986) 1.84
Influence of digital and analogue cellular telephones on implanted pacemakers. Eur Heart J (1997) 1.82
Cisplatin biochemical mechanism of action: from cytotoxicity to induction of cell death through interconnections between apoptotic and necrotic pathways. Curr Med Chem (2003) 1.81
Differential expression of ZAP-70 and Syk protein tyrosine kinases, and the role of this family of protein tyrosine kinases in TCR signaling. J Immunol (1994) 1.80
Honeybee colony collapse due to Nosema ceranae in professional apiaries. Environ Microbiol Rep (2009) 1.79
A simple radioimmunoassay of plasma testosterone without column chromatography. Steroids (1974) 1.78
A pilot experience with permanent biventricular pacing to treat advanced heart failure. Am Heart J (2000) 1.78
Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect. Oncogene (2008) 1.78
Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial. J Hepatol (1998) 1.76
Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group. Lancet (2000) 1.76
Identification of a novel insulin-sensitive glycophospholipid from H35 hepatoma cells. J Biol Chem (1987) 1.75
Prostatic-specific antigen: an immunohistologic marker for prostatic neoplasms. Cancer (1981) 1.73
Potential role of protein kinase B in glucose transporter 4 translocation in adipocytes. Endocrinology (1997) 1.73
Cross-talk between the proto-oncogenes Met and Ron. Oncogene (2000) 1.71
Macrophage proteomic fingerprinting predicts HIV-1-associated cognitive impairment. Neurology (2003) 1.70
Programmed cell death in mature erythrocytes: a model for investigating death effector pathways operating in the absence of mitochondria. Cell Death Differ (2001) 1.69
Increased expression of NK cell markers on T lymphocytes in aging and chronic activation of the immune system reflects the accumulation of effector/senescent T cells. Mech Ageing Dev (2000) 1.68
Hepatitis C virus antibodies in chronic alcoholic patients: association with severity of liver injury. Hepatology (1990) 1.67
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Consensus nomenclature for the mammalian methionine adenosyltransferase genes and gene products. Trends Genet (1997) 1.67
Induction of tumor necrosis factor alpha production by human hepatocytes in chronic viral hepatitis. J Exp Med (1994) 1.66
Role of MAPKs in development and differentiation: lessons from knockout mice. Biochimie (2006) 1.65
The long-term course of chronic hepatitis B. Hepatology (1999) 1.63
3':5'-cyclic AMP-dependent 3':5'-cyclic GMP accumulation in Dictyostelium discoideum. Proc Natl Acad Sci U S A (1977) 1.62
Defect in skeletal muscle phosphatidylinositol-3-kinase in obese insulin-resistant mice. J Clin Invest (1993) 1.62
Single shock endocavitary low energy intracardiac cardioversion of chronic atrial fibrillation. J Interv Card Electrophysiol (1999) 1.60
Radiofrequency catheter ablation of idiopathic left ventricular outflow tract tachycardia: utility of intracardiac echocardiography. J Cardiovasc Electrophysiol (2001) 1.57
Differential expression of methionine adenosyltransferase genes influences the rate of growth of human hepatocellular carcinoma cells. Cancer Res (1998) 1.56
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Changes in S-adenosylmethionine synthetase in human liver cancer: molecular characterization and significance. Hepatology (1996) 1.56
Characterization for enterotoxin production, virulence factors, and antibiotic susceptibility of Staphylococcus aureus isolates from various foods in Portugal. Food Microbiol (2009) 1.53
Adiponectin and its receptors in non-alcoholic steatohepatitis. Gut (2005) 1.53
Evaluation of brain natriuretic peptide in the diagnosis of heart failure. Cardiology (2000) 1.53
Insulin receptor tyrosine kinase is defective in skeletal muscle of insulin-resistant obese mice. Nature (1985) 1.50
Effect of fasting and streptozotocin diabetes on insulin binding and action in the isolated mouse soleus muscle. J Clin Invest (1979) 1.50
Efficacy of triple therapy with a proton pump inhibitor, levofloxacin, and amoxicillin as first-line treatment to eradicate Helicobacter pylori. Rev Esp Enferm Dig (2009) 1.49
Changes in methionine adenosyltransferase and S-adenosylmethionine homeostasis in alcoholic rat liver. Am J Physiol Gastrointest Liver Physiol (2000) 1.48
Immunoglobulin G- and M-specific enzyme-linked immunosorbent assay for detection of dengue antibodies. J Clin Microbiol (1979) 1.48
A head-to-tail tandem organization of hsp70 genes in Trypanosoma cruzi. Nucleic Acids Res (1988) 1.47
Overexpression of a constitutively active form of phosphatidylinositol 3-kinase is sufficient to promote Glut 4 translocation in adipocytes. J Biol Chem (1996) 1.46
Changes in methionine adenosyltransferase during liver regeneration in the rat. Am J Physiol (1998) 1.46
[Gene expression in obese patients with non-alcoholic steatohepatitis]. Rev Esp Enferm Dig (2008) 1.45
The APC is dispensable for first meiotic anaphase in Xenopus oocytes. Nat Cell Biol (2001) 1.43
Transoesophageal low-energy cardioversion of atrial fibrillation. Results with the oesophageal-right atrial lead configuration. Eur Heart J (2000) 1.43
Chemotaxis and binding of cyclic AMP in cellular slime molds. Biochim Biophys Acta (1975) 1.43
Indium-111-antimyosin scintigraphy after doxorubicin therapy in patients with advanced breast cancer. J Nucl Med (1990) 1.43
Radioimmune imaging of bone marrow in patients with suspected bone metastases from primary breast cancer. J Nucl Med (1990) 1.42
Ultrasound changes in abdominal echinococcosis treated with albendazole. J Clin Ultrasound (1991) 1.42
Flutamide-induced hepatotoxicity: report of a case series. Rev Esp Enferm Dig (2001) 1.42
Colorectal adenocarcinoma: quality of the assessment of lymph node metastases. Dis Colon Rectum (1994) 1.42
[Prevalence of eating disorders in a representative sample of female adolescents from Navarra (Spain)]. Med Clin (Barc) (2000) 1.41
Activation of phospholipid methyltransferase by glucagon in rat hepatocytes. J Biol Chem (1980) 1.41
Observation of B(0)(s)-->Psi(2S)Phi and measurement of the ratio of branching fractions Beta(B(0)(s)-->Psi(2S)Phi)/Beta(B(0)(s)-->J/PsiPhi). Phys Rev Lett (2006) 1.40
MAP kinases and mTOR mediate insulin-induced phosphorylation of insulin receptor substrate-1 on serine residues 307, 612 and 632. Diabetologia (2003) 1.40
[Prospective epidemiologic study of perioperative anaphylactoid reactions occurring in Catalonia (1996-7)]. Rev Esp Anestesiol Reanim (2002) 1.40
Cyclic AMP and folic acid mediated cyclic GMP accumulation in Dictyostelium discoideum. FEBS Lett (1977) 1.40
Interaction between cyclin T1 and SCF(SKP2) targets CDK9 for ubiquitination and degradation by the proteasome. Mol Cell Biol (2001) 1.40
Phosphodiesterase inhibitory properties of losartan. Design and synthesis of new lead compounds. Bioorg Med Chem Lett (1998) 1.40